Retrospective Analysis of Eculizumab in Patients with Acetylcholine Receptor Antibody-Negative Myasthenia Gravis: A Case Series

BACKGROUND: The role of the complement cascade in acetylcholine receptor antibody-negative (AChR–) myasthenia gravis (MG) is unclear. OBJECTIVE: To assess the efficacy and tolerability of eculizumab (terminal complement inhibitor) in patients with AChR–MG. METHODS: Retrospective chart review of data...

Descripción completa

Detalles Bibliográficos
Autores principales: Datta, Sorabh, Singh, Shivangi, Govindarajan, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369065/
https://www.ncbi.nlm.nih.gov/pubmed/32444555
http://dx.doi.org/10.3233/JND-190464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369065/
https://www.ncbi.nlm.nih.gov/pubmed/32444555
http://dx.doi.org/10.3233/JND-190464

Ejemplares similares